Paushak Ltd, India's largest phosgene-based speciality chemical manufacturer, announced a 2-for-1 stock split (₹10 to ₹5 face value) followed by a 3:1 bonus issue. This aims to boost public participation. The authorised share capital will be reclassified to ₹20 crore. Bonus shares are expected by October 10, 2025. Q1FY26 revenue was ₹56 crore with ₹12 crore net profit.